Follow The Filings

EDIT Editas Medicine

Editas Medicine earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by EDIT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All EDIT insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 14 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01
SCHEDULE 13G —
8-K 2.02,5.02,9.01
10-Q
SCHEDULE 13G/A —
8-K 5.07
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G —
8-K 7.01,8.01,9.01
424B5
8-K 8.01
8-K 1.01,8.01,9.01
424B5
8-K 7.01,8.01,9.01
8-K 2.02,9.01
10-Q
DEF 14A
DEFA14A
8-K 4.01,9.01
8-K 7.01,8.01,9.01
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.